Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease

FGF-1 for the treatment of patients with peripheral arterial disease with intermittent claudication.

Participants needed: 24
Trial details
Phase: Phase 1, Phase 2Age: 50-75Biological sex: AllType: InterventionalSponsor: Venturis Therapeutics, Inc.Updated: Aug 19, 2026Locations: 1
Eligibility criteria

Subjects considered eligible to enter the study must sign an informed consent fo... [+6]

Evidence of critical leg ischemia, i.e. ischemic rest pain or ischemic ulceratio... [+29]

Status: Not yet recruiting

Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease

Treatment for no-option heart patients with coronary artery disease. Procedure includes the injection into the heart of a protein growth factor, administered by the Biological Delivery Systems MyoStar injection and mapping catheters, to stimulate the growth of blood vessels around blocked coronary arteries.

Participants needed: 150
Trial details
Phase: Phase 2Age: 25-75Biological sex: AllType: InterventionalSponsor: Venturis Therapeutics, Inc.Updated: Aug 19, 2026
Eligibility criteria

Sign an informed consent form. [+17]

History of undergoing a CABG, PTCA or TMR or evidence of an acute MI in the last... [+29]